• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ιnfluenza A(H3N2) genetic variants in vaccinated patients in northern Greece

tetano

Editor, Senior Moderator
J Clin Virol. 2017 Jul 14;94:29-32. doi: 10.1016/j.jcv.2017.07.003. [Epub ahead of print]
[h=1]Ιnfluenza A(H3N2) genetic variants in vaccinated patients in northern Greece.[/h] Melidou A[SUP]1[/SUP], Gioula G[SUP]2[/SUP], Exindari M[SUP]2[/SUP], Ioannou E[SUP]2[/SUP], Gkolfinopoulou K[SUP]3[/SUP], Georgakopoulou T[SUP]3[/SUP], Tsiodras S[SUP]4[/SUP], Papa A[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza A(H3N2) viruses predominated during the influenza 2016/2017 season and showed extensive genetic diversification. A high vaccination failure rate was noticed during the 2016/17 season in Greece, especially among the elderly.
[h=4]OBJECTIVES:[/h] The scope of the study was to investigate the genetic characteristics of A(H3N2) circulating viruses and viruses detected in vaccinated patients.
[h=4]STUDY DESIGN:[/h] Virus samples originated from vaccinated and unvaccinated patients, obtained at the National Influenza Centre for northern Greece. Phylogenetic analysis and comparison of the haemagglutinin gene of the viruses to the vaccine virus A/Hong Kong/4801/2014 was performed.
[h=4]RESULTS:[/h] The majority of analysed viruses are clustering in the genetic clade 3C.2a, and in a newly emerged subclade, designated as 3C.2a1. The highest proportion of viruses detected in vaccinated patients fell into a distinct subcluster within the 3C.2a1 subclade, which is characterised by the amino acid substitutions N122D and T135K in haemagglutinin.
[h=4]CONCLUSIONS:[/h] Viruses that belong to the 3C.2a clade are generally considered to resemble antigenically to the northern hemisphere vaccine component A/Hong Kong/4801/2014 that was recommended by WHO to be included also into the 2017/18 vaccine. However, viruses belonging to a specific 3C.2a1 subcluster was extensively circulating in northern Greece and among vaccinated individuals. Both substitutions carried by this strain were located on antigenic sites and caused losses of N-linked glycosylation sites of the virus, which could potentially affect viral antigenicity. Further studies are needed to determine the antigenicity of this variant strain and its possible implication in vaccine effectiveness.
Copyright ? 2017. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] A(H3N2); Greece; Influenza; Vaccine; Variations

PMID: 28734139 DOI: 10.1016/j.jcv.2017.07.003
 
Back
Top Bottom